Coherus Oncology, Inc.
CHRS$1.58▲ 7.14% 24h
Coherus Oncology, Inc.CHRS$1.58
+$0.6691(+73.87%)Past Year
Jun 25Sep 25Dec 25Mar 26Jun 26
Key statistics
Market cap
$236.08M
P/E ratio
1.1
EPS (diluted)
$1.43
Dividend yield
0.00%
Dividend / share
$0.00
Revenue
$42.17M
Net income
$168.02M
Net margin
398.4%
Gross margin
275.2%
Dividends & financials
Coherus Oncology, Inc. (CHRS) reported revenue of $42.17M and net income of $168.02M, or $1.43 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.